Clinical Trial

Nicotine Content Cigarettes in a Complex Marketplace

Study Description

Impact of Very Low Nicotine Content Cigarettes in a Complex Marketplace

This project will examine the impact of very low nicotine content (VLNC) cigarettes in a complex tobacco and nicotine product marketplace. We will compare the number of cigarettes smoked and cigarette-free days in an experimental marketplace that contains VLNC cigarettes versus normal nicotine content (NNC) cigarettes.

Location

Locations Selected Location

Methods

Pharmaceutical medication involved Pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Drug - Very Low Nicotine Content Cigarettes

0.4 mg/g nicotine; 9 mg tar

Drug - Normal Nicotine Content Cigarettes

15.8 mg/g nicotine; 9 mg tar

Additional Information

Official Study Title

Impact of Very Low Nicotine Content Cigarettes in a Complex Marketplace Part of "Evaluating New Nicotine Standards for Cigarettes"

Clinical Trial ID

NCT03272685

ParticipAid ID

1aKqrd